Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

4.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

75.4K
Overview
75.4K
T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

8.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
8.7K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

5.7K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
5.7K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.4K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAD: A Read-structure Agnostic Demultiplexer for Single-Cell Long-Read Sequencing and Analysis.

bioRxiv : the preprint server for biology·2026
Same author

Conversion of waste cooking oil to environmentally acceptable surfactants for enhanced oil recovery.

Scientific reports·2026
Same author

Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy.

Journal for immunotherapy of cancer·2026
Same author

The immunology of vitiligo.

Nature reviews. Immunology·2026
Same author

Evaluation of the Accuracy of Infrared Thermographic Imaging for the Diagnosis of Periodontal Diseases: A Cross-Sectional Study.

Journal of clinical periodontology·2025
Same author

Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.

bioRxiv : the preprint server for biology·2025
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
Same journal

Parental leave in immunology - 6.

Trends in immunology·2026
Same journal

T cell control of the intestinal barrier and gut microbiota during ageing.

Trends in immunology·2026
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.2K

Life support for transitory exhausted CTLs.

Asmaa Mohamed1, Yina H Huang2

  • 1Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

Trends in Immunology
|November 13, 2021
PubMed
Summary
This summary is machine-generated.

CXCR6 guides cytotoxic T lymphocytes (CTLs) to dendritic cells (DCs) in tumors, enabling survival signals. This interaction is crucial for anti-tumor immunity and predicts patient survival.

Keywords:
CXCR6–CXCL16DC3IL-15 trans-presentationperivascular nichetransitory effector T celltumor immunity

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

527

Related Experiment Videos

Last Updated: Oct 13, 2025

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.2K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

527

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Trafficking

Background:

  • Tumor immunity relies on effective interactions between immune cells within the tumor microenvironment.
  • Cytotoxic CD8+ T lymphocytes (CTLs) are critical for tumor rejection, but their survival and function can be impaired in the tumor stroma.
  • Dendritic cells (DCs) play a key role in initiating and sustaining T cell responses.

Purpose of the Study:

  • To investigate the role of the chemokine receptor CXCR6 in orchestrating the positioning of immune cells within the tumor microenvironment.
  • To elucidate the functional consequences of CXCR6-mediated cell positioning on T cell survival and anti-tumor immunity.
  • To determine the clinical relevance of CXCR6 expression and associated cellular interactions in cancer patients.

Main Methods:

  • Utilized mouse models of cancer to study immune cell infiltration and localization within tumors.
  • Employed flow cytometry and immunohistochemistry to identify and quantify specific immune cell populations (CTLs, DCs) and their spatial relationships.
  • Analyzed gene expression and signaling pathways involved in T cell survival and function, including IL-15 signaling.
  • Correlated CXCR6 expression and immune cell interactions with patient survival data.

Main Results:

  • Demonstrated that CXCR6 is essential for the proper positioning of TCF-1-negative, transitory CD8+ CTLs.
  • Showed that these CTLs are localized adjacent to perivascular CCR7+ DCs within the tumor stroma.
  • Confirmed that this CXCR6-mediated positioning facilitates the receipt of IL-15 survival signals by CTLs from DCs.
  • Found a strong correlation between CXCR6 expression and improved overall patient survival, highlighting the clinical significance of this interaction.

Conclusions:

  • CXCR6 acts as a critical regulator of immune cell positioning within the tumor microenvironment.
  • The interaction between CXCR6-expressing CTLs and CCR7+ DCs is vital for sustaining anti-tumor immunity through IL-15 signaling.
  • CXCR6-mediated CTL-DC interactions represent a promising therapeutic target for enhancing anti-tumor immunity and improving patient outcomes.